We further support public-private healthcare partnership strategies that can improve access, sustainability, and adoption in the regions where they are most needed. This combined awareness of both Western regulatory and engineering expectations and African market and operational conditions differentiates Tequa Consulting from purely Western-centric advisory models.
Healthcare innovation requires precision across engineering, compliance, manufacturing, and clinical validation, and Tequa Consulting provides integrated advisory for diagnostic technologies, biosensing systems, and broader medical device innovation. Our approach emphasizes technical-commercial alignment, including translating biosensor architectures into scalable product platforms, assessing materials and surface chemistry scalability, and evaluating manufacturing feasibility for electrochemical and optical systems.
We also support regulatory and market strategy by aligning teams to MDR/IVDR expectations in the EU, incorporating UKCA considerations, maintaining strategic awareness of potential FDA pathways, and planning evidence generation to match the intended regulatory route and intended use. In addition, we strengthen product development governance through design control structuring, risk management framework integration, and early incorporation of quality requirements to ensure progress can withstand regulatory and validation scrutiny.
Africa presents unique operating realities that shape product design and deployment outcomes, including infrastructure variability, supply chain constraints, higher out-of-pocket healthcare expenditure, and strong demand for point-of-care diagnostics. To address these factors, we advise on localized production feasibility, cost-sensitive device design choices, and deployment models suited to low-resource environments.